$175.99
+5.52
(+3.24%)▲
Insights on Nova Measuring Instruments Ltd.
Revenue is up for the last 3 quarters, 122.70M → 134.21M (in $), with an average increase of 4.4% per quarter
Netprofit is up for the last 3 quarters, 29.92M → 38.06M (in $), with an average increase of 11.3% per quarter
In the last 1 year, Lam Research Corporation has given 95.5% return, outperforming this stock by 7.6%
3.0%
Downside
Day's Volatility :4.37%
Upside
1.41%
50.08%
Downside
52 Weeks Volatility :53.89%
Upside
7.62%
Period | Nova Measuring Instruments Ltd. | Sector (Technology) | Index (Russel 2000) |
---|---|---|---|
3 Months | 32.96% | 5.2% | 0.0% |
6 Months | 69.58% | 19.1% | 0.0% |
1 Year | 87.94% | 35.2% | -1.9% |
3 Years | 88.85% | 40.8% | -21.8% |
Market Capitalization | 4.9B |
Book Value | $25.88 |
Earnings Per Share (EPS) | 4.28 |
PE Ratio | 39.83 |
PEG Ratio | 0.0 |
Wall Street Target Price | 176.6 |
Profit Margin | 26.32% |
Operating Margin TTM | 25.08% |
Return On Assets TTM | 7.81% |
Return On Equity TTM | 20.38% |
Revenue TTM | 517.9M |
Revenue Per Share TTM | 17.97 |
Quarterly Revenue Growth YOY | -11.3% |
Gross Profit TTM | 317.0M |
EBITDA | 148.5M |
Diluted Eps TTM | 4.28 |
Quarterly Earnings Growth YOY | 0.04 |
EPS Estimate Current Year | 5.4 |
EPS Estimate Next Year | 6.36 |
EPS Estimate Current Quarter | 1.23 |
EPS Estimate Next Quarter | 1.19 |
What analysts predicted
Upside of 0.35%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 251.1M | ↑ 13.13% |
Net Income | 54.4M | ↑ 17.04% |
Net Profit Margin | 21.65% | ↑ 0.72% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 224.9M | ↓ 10.44% |
Net Income | 35.2M | ↓ 35.32% |
Net Profit Margin | 15.64% | ↓ 6.01% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 269.4M | ↑ 19.78% |
Net Income | 47.9M | ↑ 36.21% |
Net Profit Margin | 17.78% | ↑ 2.14% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 416.1M | ↑ 54.46% |
Net Income | 93.1M | ↑ 94.34% |
Net Profit Margin | 22.37% | ↑ 4.59% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 570.7M | ↑ 37.16% |
Net Income | 140.2M | ↑ 50.6% |
Net Profit Margin | 24.57% | ↑ 2.2% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 517.9M | ↓ 9.25% |
Net Income | 136.3M | ↓ 2.78% |
Net Profit Margin | 26.32% | ↑ 1.75% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 143.9M | ↑ 1.61% |
Net Income | 35.1M | ↑ 0.56% |
Net Profit Margin | 24.37% | ↓ 0.26% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 132.2M | ↓ 8.14% |
Net Income | 34.6M | ↓ 1.28% |
Net Profit Margin | 26.19% | ↑ 1.82% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 132.2M | ↑ 0.0% |
Net Income | 34.6M | ↑ 0.0% |
Net Profit Margin | 26.19% | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 122.7M | ↓ 7.18% |
Net Income | 29.9M | ↓ 13.58% |
Net Profit Margin | 24.39% | ↓ 1.8% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 128.8M | ↑ 4.98% |
Net Income | 33.7M | ↑ 12.57% |
Net Profit Margin | 26.15% | ↑ 1.76% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 134.2M | ↑ 4.2% |
Net Income | 38.1M | ↑ 13.0% |
Net Profit Margin | 28.36% | ↑ 2.21% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 333.4M | ↑ 17.7% |
Total Liabilities | 52.7M | ↓ 6.82% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 400.4M | ↑ 20.1% |
Total Liabilities | 85.9M | ↑ 63.04% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 655.8M | ↑ 63.77% |
Total Liabilities | 284.2M | ↑ 230.89% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 805.2M | ↑ 22.78% |
Total Liabilities | 331.4M | ↑ 16.59% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 984.1M | ↑ 22.23% |
Total Liabilities | 397.1M | ↑ 19.84% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 15.21% |
Total Liabilities | 383.1M | ↓ 3.55% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 933.8M | ↑ 3.58% |
Total Liabilities | 380.8M | ↑ 0.47% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 9.97% |
Total Liabilities | 397.6M | ↑ 4.43% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 0.0% |
Total Liabilities | 397.6M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 1.18% |
Total Liabilities | 376.8M | ↓ 5.25% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↑ 4.34% |
Total Liabilities | 383.4M | ↑ 1.75% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↑ 4.58% |
Total Liabilities | 383.1M | ↓ 0.08% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 36.1M | ↓ 41.58% |
Investing Cash Flow | -36.7M | ↓ 35.81% |
Financing Cash Flow | -4.4M | ↓ 269.53% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 41.2M | ↑ 14.1% |
Investing Cash Flow | -25.5M | ↓ 30.61% |
Financing Cash Flow | -6.7M | ↑ 50.16% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 60.3M | ↑ 46.24% |
Investing Cash Flow | -42.5M | ↑ 66.83% |
Financing Cash Flow | 181.4M | ↓ 2820.95% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 132.3M | ↑ 119.51% |
Investing Cash Flow | -238.5M | ↑ 461.72% |
Financing Cash Flow | 11.0K | ↓ 99.99% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 119.5M | ↓ 9.62% |
Investing Cash Flow | -100.3M | ↓ 57.96% |
Financing Cash Flow | -29.8M | ↓ 271063.64% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 32.0M | ↑ 27.39% |
Investing Cash Flow | -71.4M | ↓ 253.95% |
Financing Cash Flow | -10.6M | ↑ 153.72% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 23.1M | ↓ 27.79% |
Investing Cash Flow | -41.6M | ↓ 41.7% |
Financing Cash Flow | -112.0K | ↓ 98.95% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 24.2M | ↑ 4.75% |
Investing Cash Flow | 9.1M | ↓ 121.97% |
Financing Cash Flow | 115.0K | ↓ 202.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 24.2M | ↑ 0.0% |
Investing Cash Flow | 9.1M | ↑ 0.0% |
Financing Cash Flow | 115.0K | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 46.7M | ↑ 93.18% |
Investing Cash Flow | -58.4M | ↓ 738.5% |
Financing Cash Flow | 7.0K | ↓ 93.91% |
Sell
Neutral
Buy
Nova Measuring Instruments Ltd. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Nova Measuring Instruments Ltd. | 3.32% | 69.58% | 87.94% | 88.85% | 511.93% |
Entegris, Inc. | -3.01% | 35.07% | 82.63% | 15.78% | 224.66% |
Applied Materials, Inc. | 4.36% | 46.78% | 87.39% | 60.04% | 377.28% |
Lam Research Corporation | 4.1% | 48.2% | 95.52% | 54.93% | 390.72% |
Teradyne Inc. | 2.01% | 8.71% | 6.95% | -16.93% | 133.96% |
Kla-tencor Corporation | 0.38% | 42.55% | 86.32% | 113.73% | 460.39% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Nova Measuring Instruments Ltd. | 39.83 | 39.83 | 0.0 | 5.4 | 0.2 | 0.08 | NA | 25.88 |
Entegris, Inc. | 109.73 | 109.73 | 1.58 | 3.3 | 0.05 | 0.03 | 0.0 | 22.67 |
Applied Materials, Inc. | 24.23 | 24.23 | 2.48 | 8.27 | 0.46 | 0.16 | 0.01 | 20.98 |
Lam Research Corporation | 36.49 | 36.49 | 2.72 | 29.16 | 0.42 | 0.13 | 0.01 | 62.63 |
Teradyne Inc. | 38.25 | 38.25 | 1.34 | 2.93 | 0.18 | 0.09 | 0.0 | 16.54 |
Kla-tencor Corporation | 34.37 | 34.37 | 2.73 | 22.81 | 0.96 | 0.16 | 0.01 | 22.5 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Nova Measuring Instruments Ltd. | Buy | $4.9B | 511.93% | 39.83 | 26.32% |
Entegris, Inc. | Buy | $19.8B | 224.66% | 109.73 | 5.13% |
Applied Materials, Inc. | Buy | $170.9B | 377.28% | 24.23 | 27.03% |
Lam Research Corporation | Buy | $124.0B | 390.72% | 36.49 | 24.15% |
Teradyne Inc. | Buy | $16.0B | 133.96% | 38.25 | 16.77% |
Kla-tencor Corporation | Buy | $92.1B | 460.39% | 34.37 | 27.98% |
Wasatch Advisors Inc.
FMR Inc
MENORA MIVTACHIM HOLDINGS LIMITED
Adage Capital Partners Gp LLC
Harel Insurance Invests & Fin Srvcs Ltd
Migdal Insurance & Financial Holdings Ltd
nova measuring instruments ltd. is a leading provider of advanced, high-throughput metrology solutions for semiconductor manufacturing worldwide. used by over 80% of the largest integrated-circuit manufacturers, nova’s solutions deliver the high-volume complex measurements required for effective process control. nova offers a selection of integrated and stand-alone metrology platforms, which are complimented by the powerful novamars® modeling engine. this flexible offering enables nova to partner with semiconductor manufacturers throughout the entire product lifecycle; from application development to high-volume production. featuring a unique combination of spectroscopic reflectrometry and scatterometry, nova’s metrology solutions measure a wide variety of features and parameters including cd, trench depth, photoresist height, thickness and shape of complex layer stacks. with nova, you get the tight wafer-to-wafer and within-wafer control necessary to develop and produce advance
Organization | Nova Measuring Instruments Ltd. |
Employees | 1202 |
CEO | Mr. Eitan Oppenhaim |
Industry | Electronic Technology |
Evolent Health, Inc. - Class A Shares
$175.99
+3.24%
Janux Therapeutics Inc
$175.99
+3.24%
Playtika Holding Corp
$175.99
+3.24%
Masonite International Corp
$175.99
+3.24%
Allegro Microsystems, Inc.
$175.99
+3.24%
Pegasystems Inc
$175.99
+3.24%
Roku, Inc.
$175.99
+3.24%
Intapp, Inc.
$175.99
+3.24%
Jpmorgan Betabuilders Europe Etf
$175.99
+3.24%